Jan 10, 2022 / 06:30PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
All right. Good afternoon, and welcome again to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm.
Our next presenting company this afternoon is Rocket Pharmaceuticals, and it's my pleasure to welcome Gaurav Shah, CEO, to talk to us a little bit about the company.
There is a Q&A session after the presentation. (Operator Instructions)
So with that, Gaurav, thanks for sharing some of your time with us today.
Gaurav D. Shah - Rocket Pharmaceuticals, Inc. - CEO & Director
Eric, happy New Year to you and to everybody, and thanks for joining us today. I'm going to call out the slide numbers as we go to keep it pretty simple.
So Slide 1 for now. Rocket is a clinical stage gene therapy company. Our vision is seeking gene therapy cures, very simple. The bottom line today is that we're very excited about this year for Rocket. We have multiple milestones, some readouts that could set us
Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers